GLOBAL PERIPHERAL ARTERY DISEASE MARKET FORECAST 2021-2028

The global peripheral artery disease market is anticipated to register a CAGR of 10.35% between 2021 and 2028, and is set to generate revenue of $6242.7 million by 2028.  

Peripheral artery disease (PAD) is a disease of blood vessels located outside the brain and heart. PAD occurs when plaque builds up in arteries, and the blood is carried to the head, organs, and limbs.

peripheral-artery-disease-market

Key factors propelling the global peripheral artery disease market growth is:

  • Enhanced reimbursement and insurance policies
  • Technological innovations in treatment options
  • Rising aging population
    • A rapid rise in the geriatric population is one of the major drivers of the peripheral artery disease market growth.
    • The prevalence of PAD increases with age. It occurs in 3% of people who are below 60. However, its prevalence increases to 15% to 20% among individuals more than 70 years of age.
  • Healthcare infrastructure in developing economies

Major growth restraining factors:

  • Stringent approval process
  • Occurrence of clinical failure after successful interventions
  • High competition among the market players
    • The competition in the market among companies results in decreased prices, overall impacting the overall market.
    • For surgeries involving peripheral vascular diseases, the choice of devices is vast, and the number of patients is large. Here, a fragmented market is created due to an increased number of companies and consumers.

The report scope of the global peripheral artery disease market includes the segmentation analysis of devices. The devices segment is further classified to provide a detailed analysis of the studied market.

Market by Devices:

  • Peripheral Stents
    • Peripheral stents are the major revenue-generating segment in the devices category.
    • Peripheral stents are often composed of a nitinol base and maybe plain, drug-coated, or covered with prosthetic material. The segment’s growth is propelled by several technological innovations, which lead to the development of EPC capture and dual therapy stents and bioengineered stents.
    • Peripheral stents are further divided into self-expandable, balloon-expandable, covered, and drug-eluting stents.
  • Peripheral Angioplasty Balloons
  • Plaque Modification Devices
  • Inferior Vena Cava (IVC) Filters
  • Hemodynamic Flow Alteration Devices
  • Peripheral Catheters
  • Peripheral Accessories

Geographically, the global peripheral artery disease market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America held the largest market share in the global market as of 2020.
    • This is mainly attributed to the geriatric population growth and the increasing number of diabetes and blood pressure patients with complications. Also, technological advancements in peripheral artery disease devices promote market growth. In the United States, the patient pool's rise is a key driver of the market growth.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia-Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific
    • Asia-Pacific is set to be the fastest-growing region in the global market by 2028.
    • Due to the increasing aging population, the rising demand for advanced peripheral artery disease devices in the region.
    • China is a lucrative market for peripheral artery disease, owing to its dense population base. The number of patients suffering from chronic diseases is high in the country.
  • Rest of World: Latin America, the Middle East & Africa

The major players in the global peripheral artery disease market are:

  • Abbott Laboratories
  • Bayer AG
  • B Braun Melsungen AG
  • Becton, Dickinson and Company (C R Bard)
  • Medtronic Plc
  • Others

Key strategies adopted by some of the peripheral artery disease companies:

In September 2020, AngioDynamics launched the Auryon Atherectomy System, a newly-established innovative expertise for the conduct of peripheral artery disease, including In-Stent Restenosis (ISR) and Critical Limb Ischemia (CLI).

Key findings of the global peripheral artery disease market:

  • There are immense growth opportunities in developing countries.
  • There is a growing awareness among patients about treatment options.

 

Frequently Asked Questions (FAQs):

The peripheral artery disease market has witnessed advancements in treatment options in the past few years. Technological innovations that have led to development are bio-engineered stents, EPC capture stents, and dual therapy stents. All these developments are anticipated to boost the market growth during the forecast period.
During the COVID-19 epidemic, the non-emergency peripheral arterial procedures were delayed, as suggested by the experts, for providing the hospital beds and healthcare for COVID-19 patients. Also, patients were reasonably apprehensive about receiving treatment during the pandemic, thereby affecting the market growth.
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. ENHANCED REIMBURSEMENT AND INSURANCE POLICIES
      2. TECHNOLOGICAL INNOVATIONS IN TREATMENT OPTIONS
      3. RISING AGING POPULATION
      4. HEALTHCARE INFRASTRUCTURE IN DIFFERENT ECONOMIES
    2. KEY RESTRAINTS
      1. STRINGENT APPROVAL PROCESS
      2. OCCURRENCE OF CLINICAL FAILURE AFTER SUCCESSFUL INTERVENTIONS
      3. HIGH COMPETITION AMONG THE MARKET PLAYERS
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON PERIPHERAL ARTERY DISEASE MARKET
    2. KEY INVESTMENT INSIGHTS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY DEVICES
    1. PERIPHERAL STENTS
      1. SELF-EXPANDABLE
      2. BALLOON-EXPANDABLE
      3. COVERED
      4. DRUG-ELUTING STENTS
    2. PERIPHERAL ANGIOPLASTY BALLOONS
      1. OLD/NORMAL BALLOONS
      2. CUTTING & SCORING BALLOONS
      3. DRUG-COATED BALLOONS
    3. PLAQUE MODIFICATION DEVICES
      1. THROMBECTOMY DEVICES
        1. MECHANICAL
        2. ASPIRATION
        3. RHEOLYTIC
      2. ATHERECTOMY DEVICES
    4. INFERIOR VENA CAVA (IVC) FILTERS
      1. PERMANENT FILTERS
      2. RETRIEVABLE FILTERS
    5. HEMODYNAMIC FLOW ALTERATION DEVICES
      1. EMBOLIC PROTECTION DEVICES
      2. CHRONIC TOTAL OCCLUSION DEVICES
    6. PERIPHERAL CATHETERS
      1. ANGIOGRAPHY CATHETERS
      2. GUIDING CATHETERS
    7. PERIPHERAL ACCESSORIES
      1. PERIPHERAL VASCULAR CLOSURE DEVICES
      2. GUIDEWIRES
      3. BALLOON INFLATION DEVICES
      4. INTRODUCER SHEATHS
  6. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. GERMANY
        2. FRANCE
        3. UNITED KINGDOM
        4. ITALY
        5. RUSSIA
        6. BELGIUM
        7. POLAND
        8. REST OF EUROPE
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. INDIA
        4. AUSTRALIA & NEW ZEALAND
        5. SOUTH KOREA
        6. INDONESIA
        7. THAILAND
        8. VIETNAM
        9. REST OF ASIA-PACIFIC
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGE
      4. KEY PLAYERS
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
        2. MIDDLE EAST & AFRICA
  7. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
      2. ANGIODYNAMICS INC
      3. BAYER AG
      4. B BRAUN MELSUNGEN AG
      5. BIOTRONIK INC
      6. BECTON, DICKINSON AND COMPANY (C R BARD)
      7. BOSTON SCIENTIFIC CORPORATION
      8. CARDINAL HEALTH INC
      9. COOK MEDICAL INC
      10. KONINKLIJKE PHILIPS NV (PHILIPS)
      11. MEDTRONIC PLC
      12. TELEFLEX MEDICAL
      13. TERUMO CORPORATION
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PERIPHERAL ARTERY DISEASE

TABLE 2: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY DEVICES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY DEVICES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL PERIPHERAL STENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL PERIPHERAL STENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL PERIPHERAL CATHETERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL PERIPHERAL CATHETERS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL PERIPHERAL ACCESSORIES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL PERIPHERAL ACCESSORIES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: LEADING PLAYERS OPERATING IN NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET

TABLE 23: EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 24: EUROPE PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 25: LEADING PLAYERS OPERATING IN EUROPE PERIPHERAL ARTERY DISEASE MARKET

TABLE 26: ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: LEADING PLAYERS OPERATING IN ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET

TABLE 29: REST OF WORLD PERIPHERAL ARTERY DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 30: REST OF WORLD PERIPHERAL ARTERY DISEASE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 31: LEADING PLAYERS OPERATING IN REST OF WORLD PERIPHERAL ARTERY DISEASE MARKET

TABLE 32: LIST OF MERGERS & ACQUISITIONS

TABLE 33: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 34: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 35: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

FIGURE 1: NUMBER OF AGING POPULATION BY REGION 2017 & 2050 (IN MILLION)

FIGURE 2: KEY INVESTMENT INSIGHTS

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY DEVICES, IN 2020

FIGURE 7: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL STENTS, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL PERIPHERAL STENTS MARKET, BY SELF-EXPANDABLE, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL PERIPHERAL STENTS MARKET, BY BALLOON-EXPANDABLE, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL PERIPHERAL STENTS MARKET, BY COVERED, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL PERIPHERAL STENTS MARKET, BY DRUG-ELUTING STENTS, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY OLD/NORMAL BALLOONS, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY CUTTING & SCORING BALLOONS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY DRUG-COATED BALLOONS, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY PLAQUE MODIFICATION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL PLAQUE MODIFICATION DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL THROMBECTOMY DEVICES MARKET, BY MECHANICAL, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL THROMBECTOMY DEVICES MARKET, BY ASPIRATION, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL THROMBECTOMY DEVICES MARKET, BY RHEOLYTIC, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL PLAQUE MODIFICATION DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY INFERIOR VENA CAVA (IVC) FILTERS, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY PERMANENT FILTERS, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY RETRIEVABLE FILTERS, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY HEMODYNAMIC FLOW ALTERATION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY CHRONIC TOTAL OCCLUSION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL PERIPHERAL CATHETERS MARKET, BY ANGIOGRAPHY CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 30: GLOBAL PERIPHERAL CATHETERS MARKET, BY GUIDING CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 31: GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL ACCESSORIES, 2021-2028 (IN $ MILLION)

FIGURE 32: GLOBAL PERIPHERAL ACCESSORIES MARKET, BY PERIPHERAL VASCULAR CLOSURE DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 33: GLOBAL PERIPHERAL ACCESSORIES MARKET, BY GUIDEWIRES, 2021-2028 (IN $ MILLION)

FIGURE 34: GLOBAL PERIPHERAL ACCESSORIES MARKET, BY BALLOON INFLATION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 35: GLOBAL PERIPHERAL ACCESSORIES MARKET, BY INTRODUCER SHEATHS, 2021-2028 (IN $ MILLION)

FIGURE 36: NORTH AMERICA PERIPHERAL ARTERY DISEASE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 37: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: CANADA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: EUROPE PERIPHERAL ARTERY DISEASE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 40: GERMANY PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: FRANCE PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: UNITED KINGDOM PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: ITALY PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: RUSSIA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: BELGIUM PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: POLAND PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: REST OF EUROPE PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 49: CHINA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: JAPAN PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: INDIA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: AUSTRALIA & NEW ZEALAND PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 53: SOUTH KOREA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 54: INDONESIA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 55: THAILAND PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 56: VIETNAM PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 57: REST OF ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 58: REST OF WORLD PERIPHERAL ARTERY DISEASE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 59: LATIN AMERICA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 60: MIDDLE EAST & AFRICA PERIPHERAL ARTERY DISEASE MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample